POINT 1
-
1
The number of hypertensive patients in Japan is estimated to be ∼43 million (Evidence level: E-III).
-
2
Cardiovascular disease/stroke/myocardial infarction/chronic kidney disease morbidity and mortality risks increase with blood pressure elevation beyond optimal blood pressure levels (systolic blood pressure: <120 mm Hg; and diastolic blood pressure: <80 mm Hg; Evidence level: E-Ia).
-
3
The annual number of deaths due to hypertension in Japan is estimated to be ∼100 000. It follows that of deaths due to smoking. Approximately 50% of deaths from cardiovascular diseases and 50% or more of deaths from stroke are estimated to be attributed to high blood pressure levels beyond optimal values (Evidence level: E-Ia).
-
4
Among blood pressure parameters, systolic blood pressure more strongly predicts the cardiovascular disease risk. In the presence of other risk factors, this risk increases further (Evidence level: E-Ia).
-
5
The mean salt intake among the Japanese remains high. Reducing salt intake is important for lowering the blood pressure levels of the Japanese. Furthermore, the prevalence of obesity-related hypertension has increased (Evidence level: E-III).
-
6
In Health Japan 21 (II), a 4-mm Hg decrease in the average systolic blood pressure level of the Japanese within 10 years is targeted by promoting strategies for diet/physical activities/alcohol consumption. If this is achieved, the annual number of deaths from stroke will decrease by ∼10,000 and that of deaths from coronary heart disease will decrease by ∼5,000 (Evidence level: E-Ia).
1. CURRENT STATUS OF BLOOD PRESSURE LEVELS IN THE JAPANESE AND THEIR CHANGES
According to the National Health and Nutrition Survey in 2010, 60 and 45% of Japanese men and women, respectively, aged over 30 years were regarded as having hypertension (systolic blood pressure: 140 mm Hg or more; or diastolic blood pressure: 90 mm Hg or more; or treatment with antihypertensive drugs).1 An analysis of changes in the hypertension prevalence/treatment/control rates over 30 years, from NIPPON DATA80 (1980) until NIPPON DATA2010 (2010), involving the National Survey of Circulatory Disorders, showed that the prevalence of hypertension was higher at a more advanced age, and that it exceeded 60% in men aged 50 years or older and in women aged 60 years or older (Figure 1-1a).2,3 On the basis of the prevalence of hypertension in NIPPON DATA2010, the number of hypertensive patients in 2010 in Japan was estimated to be ∼43 million (23 million men and 20 million women; Figure 1-2).2,3 Although there is a decrease in the prevalence of hypertension in women in each age group, men aged over 50 years may show a plateau or increase. With the rapid aging of society, the number of hypertensive patients in Japan may further increase in the future.
The treatment rate (proportion of patients receiving antihypertensive drugs among those with hypertension) has increased during the past 30 years. The rates were 50% or more in men and women aged 60–69 years and 60% or more in those aged 70–79 years (Figure 1-1b).2,3 In addition, the control rate (proportion of patients with a blood pressure of <140/90 mm Hg among those receiving antihypertensive drugs) has also increased during the past 30 years, reaching ∼30 and 40% in men and women, respectively (Figure 1-1c).2,3
On the other hand, the average systolic blood pressure of the Japanese was higher at a more advanced age regardless of gender. However, in all age groups, it has markedly decreased during the past 50 years (Figure 1-3a);3 there was a 10- to 20-mm Hg decrease in each age group among both men and women. The age-adjusted mortality rate due to stroke in Japan reached a peak in the 1960s. It then rapidly decreased (men 361, women 244, in 1965; men 47, women 26, in 2011 (per 100 000 persons)),4 and the life expectancy of the Japanese became the longest in the world, which may be largely due to the decrease in average blood pressure among the Japanese. A similar tendency was also noted in other epidemiological studies in Japan.5,6 The widespread introduction of hypertension screening in health checkups, advances in hypertension treatment with antihypertensive drugs or its widespread application, and changes in Japanese lifestyle/environmental factors, such as a decrease in salt intake, may have contributed to such a reduction in the average blood pressure of the Japanese. However, it should be noted that there has been no marked decrease in the average diastolic blood pressure of men aged 30–59 years during the past 50 years (Figure 1-3b).3
2. ASSOCIATION BETWEEN HYPERTENSION AND VARIOUS DISEASES
1) Hypertension-related increase in the risk for stroke/heart disease
Hypertension is the most important risk factor for cardiovascular diseases (stroke and heart disease). In the 1960s, Japan was one of the countries with the highest mortality rate due to stroke. The mortality/morbidity rates due to stroke are still higher than those due to acute myocardial infarction.7 However, the mortality rate due to stroke has markedly decreased during the past 50 years, and the mortality rate from all heart diseases, including heart failure, has become higher than that due to stroke. The age-adjusted mortality rate due to stroke in Japan was about three times higher than that due to acute myocardial infarction.7 Several epidemiological studies have also reported that the morbidity rate from stroke was about four times higher than that from acute myocardial infarction.5,6,8 With respect to the subtype of stroke, recently, the morbidity rate from cerebral infarction was two to three times higher than that from cerebral hemorrhage.5,9 On the other hand, the morbidity rate from myocardial infarction has slightly increased in urban areas.6,10 In the Suita Study, the morbidity rate from stroke was about two times higher than that from acute myocardial infarction, showing a reduction in the difference.11,12
There is a graded, continuous, positive association between blood pressure level and risk for cardiovascular diseases.9,13,14,15,16,17,18,19In a project to integrate major cohort studies in Japan, EPOCH-JAPAN, a meta-analysis of 10 cohort studies (total: ∼70,000 persons) showed that the association between blood pressure level and cardiovascular disease mortality risk was almost logarithmically linear in middle-aged (40–64 years) and early-phase elderly (65–74 years) people. The slope was stronger in younger people, and the risk was lowest in those with optimal blood pressure (Figure 1-4).13 In late-phase elderly people (75–89 years), the cardiovascular mortality risk also increased with blood pressure level. An analysis excluding deaths during the first 3 years of follow-up to eliminate the reverse causation indicated a significant increase in the risk from high-normal blood pressure. This association has been similarly observed when reviewing mortality due to all subtypes of stroke, cerebral infarction, cerebral hemorrhage or coronary heart disease.13,14 In particular, the association with mortality due to cerebral hemorrhage is stronger.
The results of cohort studies investigating morbidity as an outcome in Japan also showed a similar association.9,15,16 The associations between blood pressure level and stroke/coronary heart disease morbidity risks were graded and continuous. The risks were the lowest in the optimal blood pressure group. The Hisayama Study clarified the association between lacunar infarction, as a subtype of cerebral infarction, and blood pressure.16
Recent cohort studies have indicated the population-ttributable fraction, which reflects the proportion of excess cardiovascular disease mortality/morbidity related to high blood pressure exceeding optimal values.9,13,14,15,16,20 According to EPOCH-JAPAN, high blood pressure exceeding optimal values explained 50% of all cardiovascular disease deaths, 52% of stroke deaths and 59% of deaths from coronary heart disease. The number of excess deaths from grade I hypertension was the largest.13 With respect to cardiovascular morbidity, this rate was also reported. In the Japan Public Health Center Study, excess stroke morbidity due to high blood pressure exceeding optimal values was 64% in men and 50% in women. In the Hisayama Study, the proportions were 52, 36, 76 and 25% for stroke, cerebral infarction, cerebral hemorrhage and coronary heart disease, respectively.15,20 The Circulatory Risk in Communities Study indicated that the portion of excess stroke morbidity from mild hypertension has been increasing and that from severe hypertension has been decreasing.9 Lifestyle modification in persons with high-normal blood pressure or grade I hypertension and strategies to prevent the development of hypertension are further important.
2) Hypertension and other conditions/total mortality
Hypertension increases the risk for chronic kidney disease and end-stage renal disease.21,22,23 A cohort study in Okinawa showed that the future risk of end-stage renal disease increased by ∼30% per 10-mm Hg increase in systolic blood pressure.21 The Hisayama Study indicated that hypertension, especially in middle-aged persons, increased the risk for senile vascular dementia.24 Another study reported that middle-age hypertension increased the risk of reduction in future activities of daily living.25
Hypertension also increases the total mortality risk through various diseases described above. A meta-analysis involving 13 cohorts in Japan (total: 180 000 persons; EPOCH-JAPAN) revealed that the total mortality risk elevated with an increase in blood pressure in both men and women aged 40–89 years.26 It was estimated that high blood pressure exceeding optimal values could be attributed to ∼20% of all-cause deaths. An estimation on the basis of the results of previous epidemiological studies showed that hypertension is the second most important factor of death in Japan, following smoking, and the annual number of deaths due to hypertension was estimated to be ∼100 000 (Figure 1-5).27 According to NIPPON DATA80, the average hypertension-related shortening of life expectancy was 2.2 and 2.9 years in men and women, respectively.28
3) Accumulation of risk factors, metabolic syndrome and risk for cardiovascular disease
When other established risk factors accumulate in the presence of hypertension, the risk for cardiovascular diseases increases further.29,30,31,32,33 Many cohort studies in Japan and their meta-analyses have revealed an increase in cardiovascular disease risk with the accumulation of smoking, diabetes, hypercholesterolemia or chronic kidney disease in the presence of hypertension.
Metabolic syndrome is also a condition involving high blood pressure as a factor. Many cohort studies in Japan have reported a metabolic syndrome-related increase in the risk for cardiovascular diseases. Cardiovascular disease morbidity and mortality risks increased 1.5- to 2.4-fold.34,35,36 On the other hand, several cohort studies investigating cardiovascular disease morbidity/mortality as an end point37,38,39,40,41,42 have suggested that the accumulation of metabolic risk factors is important regardless of the presence or absence of obesity. In addition, the integrated analysis of 10 cohort studies including these also confirmed this.43
4) Various blood pressure parameters and cardiovascular disease risk
With respect to the association between various blood pressure parameters and the risk for cardiovascular diseases, large-scale meta-analyses have shown that systolic blood pressure most strongly predicts the future risk.44,45,46 In a meta-analysis involving 16 cohorts in Japan (the Japan Arteriosclerosis Longitudinal Study), systolic blood pressure was the strongest predictor of stroke morbidity risk in both middle-aged/elderly men and women, followed by diastolic blood pressure. The prediction ability of pulse pressure was less strong.44 Concerning hemorrhagic stroke morbidity in men, diastolic blood pressure was the strongest predictor.
In most studies investigating the association between blood pressure and risk for cardiovascular diseases, blood pressure measured in the clinic or during health checkup was used. However, the risk-prediction ability of blood pressure measured at home has been reported to be stronger.47 Furthermore, ambulatory 24-h blood pressure is also more useful than clinic blood pressure for predicting the cardiovascular disease risk.48,49,50
3. CHARACTERISTICS OF HYPERTENSION IN THE JAPANESE
1) High salt intake
An excessive intake of salt was one of the causes for the high prevalence of hypertension and stroke in the past in Japan. A high salt intake increases blood pressure. The INTERSALT Study showed that blood pressure was high in groups with a high salt intake estimated by 24-h urine collection, and that a positive correlation was present between salt intake and blood pressure in individuals.51
Although few studies have strictly evaluated salt intake using 24-h urine collection in the general population, the mean salt intake of men and women was 12.3 and 10.9 g per day, respectively, according to the INTERMAP Study, in which salt intake was measured in men and women aged 40–59 years in Hokkaido, Toyama, Shiga and Wakayama between 1996 and 1999.52 The results of the National Health and Nutrition Survey in 2011 showed that the mean daily salt intake per person was 10.4 g (men: 11.4 g, women: 9.4 g); it has gradually decreased.53 According to previous studies using 24-h urine collection, salt intake in the Tohoku District in the 1950s was estimated to reach 25 g per day.54
In the Dietary Reference Intake in Japanese (2010), the dietary goal of salt intake to be achieved in adult men and women in the next 5 years is <9.0 and <7.5 g per day, respectively.55 However, according to the National Health and Nutrition Survey in 2009, salt intake exceeded the target value in ∼70% of men and women. Health Japan 21 (II)(2012) targeted a reduction in the average salt intake of the Japanese to 8.0 g before 2022.56 In the World Health Organization guidelines on sodium intake, which were published in 2012, it is recommended that salt intake should be reduced to <5 g per day in adults.57 The current status in Japan is still far from this recommendation.
The INTERSALT Study estimated that a decrease of 6 g per day in salt intake would reduce an increase in systolic pressure after 30 years of age by 10–11 mm Hg.51 Further efforts to reduce salt intake are necessary for preventing hypertension in Japan.
2) Increases in the prevalence of obesity and metabolic syndrome
Obesity is less common in Japan than in other developed, industrialized countries. However, body mass index (kg m−2), which is an index of obesity, is found to increase substantially in men; the proportion of obesity in men has increased by about twofold during the past 30 years.58 According to the National Health and Nutrition Survey in 2011, the proportion of obesity (body mass index: 25 kg m−2 or more) in men aged 20–69 years was 32%.53 On the other hand, there was no overall increase in the proportion of obesity in women.
Regarding the characteristics of hypertensive Japanese, lean hypertensives with a high salt intake account for a high percentage, but the number of obese hypertensives has recently increased, particularly among men. According to NIPPON DATA, the proportion of hypertensive men in whom obesity contributed to hypertension increased from 11 to 27% between 1980 and 2010, and that of hypertensive women from 19 to 26%.2 This would reflect an increase in the prevalence of metabolic syndrome in Japan. The National Health and Nutrition Survey in 2010 showed that metabolic syndrome was strongly suspected in more than 30% of men aged over 50 years and in ∼20% of women aged over 60 years.1
In the United States, the prevalence of obesity has markedly increased since 1990, and those with a body mass index of 30 kg m−2 or more account for more than 30% of the population.59 In Japan, the percentage is ∼3%. However, it may increase with the westernization of lifestyle in the future. Strategies to prevent obesity must be promoted.
4. PUBLIC HEALTH MEASURES AGAINST HYPERTENSION
As shown by many epidemiological studies, more than half of high blood pressure-related excessive cardiovascular mortality/morbidity events occurred in people with mildly high blood pressure (grade I hypertension or lower).9,13,14,15,16To reduce excess cardiovascular disease mortality/morbidity, high-risk strategies involving hypertensive patients alone are insufficient. Population strategies to lower the blood pressure distribution of the whole population (the whole Japanese nation) are necessary.60,61
The ‘National Health-Promotion Project in the 21st Century’ (Health Japan 21 (II)), which was announced by the Minister of Health, Labour and Welfare in 2012, targets a decrease in average systolic blood pressure in Japan by 4 mm Hg (men: 138 → 134 mm Hg, women: 133 → 129 mm Hg) within 10 years (before 2022).56 The goal is to lower the blood pressure distribution of the whole Japanese nation (Figure 1-6).
The establishment of target values for cardiovascular diseases in Health Japan 21 (II) is presented in Figure 1-7. A 2.3-mm Hg decrease in systolic blood pressure is targeted through nutritional/dietary strategies such as reducing salt intake (to 8 g per day), increasing vegetable/fruit intake (to 350 g per day) and decreasing the number of obese people. A 1.5-mm Hg decrease is targeted through physical activity/exercise strategies (∼1,500 step increase in the number of steps). A 0.12-mm Hg decrease is targeted through alcohol strategies (decreasing the number of heavy drinkers). A 0.17-mm Hg decrease is targeted through strategies regarding antihypertensive therapy (increasing the compliance rate by 10%). Overall, a 4-mm Hg decrease in systolic blood pressure is targeted.62
In Health Japan 21 (II), the cardiovascular disease-reducing effects of target achievement were estimated using the EPOCH-JAPAN database.62 Overall, the project targets to decrease age-adjusted mortality for stroke (cerebrovascular disease) in men and women by 15.7 and 8.3%, respectively, and that for coronary heart disease (ischemic heart disease) by 13.7 and 10.4%, respectively, as shown in Figure 1–7. To achieve these goals, the role of blood pressure reduction is important. In brief, only a 4-mm Hg decrease in average systolic blood pressure in the Japanese is estimated to reduce age-adjusted mortality from stroke in men and women by 8.9 and 5.8%, respectively (the total number of deaths from stroke will decrease by ∼10 000 per year), and that for coronary heart disease by 5.4 and 7.2%, respectively (the total number of deaths from coronary heart disease will decrease by ∼5000 per year).
Population strategies to achieve the above targets include environmental approaches from various aspects, such as mass media-mediated public education, obligations regarding the labeling of salt content by food manufacturers and menu improvement/promotion of nutrition labeling in school lunch/food-service industries.63,64 It is necessary to promote high-risk strategies in parallel with population strategies. Screening and health guidance are important.65 All health/medical specialists, including physicians, nurses, public health nurses, school nurses, dietitians and pharmacists, must instruct all persons including high-risk individuals to improve their diet (salt reduction/maintenance of optimal body weight), increase physical activities and maintain moderate alcohol consumption in health care/medical practice.
Citation Information
We recommend that any citations to information in the Guidelines are presented in the following format:
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253–392.
Please refer to the title page for the full list of authors.
References
The Ministry of Health, Labour, and Welfare. The 2010 National Health and Nutrition Survey in Japan. 2012, Japanese. E-III
Miura K (chief investigator). Comprehensive research business on strategies to prevent/treat cardiovascular disease/lifestyle-related diseases such as diabetes mellitus by a scientific grant/subsidy from the Ministry of Health, Labour and Welfare, ‘Research on the start of follow-up of the subjects of the 2010 National Health and Nutrition Survey (NIPPON DATA2010) and continuation of NIPPON DATA80/90 follow-up’, Comprehensive/project study reports in 2012. 2013. Japanese. E-III
Miura K, Nagai M, Ohkubo T . Epidemiology of hypertension in Japan. Circ J 2013; 77: 2226 –2231. E-III
The Ministry of Health, Labour, and Welfare. Demographics in Japan in 2013. The Ministry of Health, Labour, and Welfare. 2013. Japanese. E-III
Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M . Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349 –2354. E-III
Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, Ohira T, Tanigawa T, Yamagishi K, Nakamura M, Konishi M, Shimamoto T, Iida M, Komachi Y . Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan 1964 to 2003: the Akita-Osaka study. J Am Coll Cardiol 2008; 52: 71 –79. E-III
Ueshima H . Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278 –286. E-III
Kimura Y, Takishita S, Muratani H, Kinjo K, Shinzato Y, Muratani A, Fukiyama K . Demographic study of first-ever stroke and acute myocardial infarction in Okinawa. Japan Intern Med 1998; 37: 736 –745. E-III
Imano H, Kitamura A, Sato S, Kiyama M, Ohira T, Yamagishi K, Noda H, Tanigawa T, Iso H, Shimamoto T . Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the Circulatory Risk in Communities Study (CIRCS). Stroke 2009; 40: 1571 –1577. E-Ib
Rumana N, Kita Y, Turin TC, Murakami Y, Sugihara H, Morita Y, Tomioka N, Okayama A, Nakamura Y, Abbott RD, Ueshima H . Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry 1990–2001. Am J Epidemiol 2008; 167: 1358 –1364. E-III
Turin TC, Kokubo Y, Murakami Y, Higashiyama A, Rumana N, Watanabe M, Okamura T . Lifetime risk of acute myocardial infarction in Japan. Circ Cardiovasc Qual Outcomes 2010; 3: 701 –703. E-III
Turin TC, Kokubo Y, Murakami Y, Higashiyama A, Rumana N, Watanabe M, Okamura T . Lifetime risk of stroke in Japan. Stroke 2010; 41: 1552 –1554. E-III
Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, Ueshima H . Observational Cohorts in Japan (EPOCH-JAPAN) Research Group. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res 2012; 35: 947 –953. E-Ia
Takashima N, Ohkubo T, Miura K, Okamura T, Murakami Y, Fujiyoshi A, Nagasawa SY, Kadota A, Kita Y, Miyagawa N, Hisamatsu T, Hayakawa T, Okayama A, Ueshima H . NIPPON DATA80 Research Group. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens 2012; 30: 2299 –2306. E-Ib
Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S . Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens 2009; 22: 273 –280. E-Ib
Arima H, Tanizaki Y, Yonemoto K, Doi Y, Ninomiya T, Hata J, Fukuhara M, Matsumura K, Iida M, Kiyohara Y . Impact of blood pressure levels on different types of stroke: the Hisayama study. J Hypertens 2009; 27: 2437 –2443. E-Ib
Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S . Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707 –716. E-Ia
Nippon Data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese—Nippon data 80. J Hum Hypertens 2003; 17: 851 –857. E-Ib
Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M . Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000; 31: 2616 –2622. E-Ib
Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y, Hirakawa Y, Matsumura K, Kitazono T, Kiyohara Y . Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study. J Hypertens 2012; 30: 893 –900. E-Ib
Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S . Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 2003; 41: 1341 –1345. E-Ib
Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A . Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159 –166. E-Ib
Kanno A, Kikuya M, Ohkubo T, Hashimoto T, Satoh M, Hirose T, Obara T, Metoki H, Inoue R, Asayama K, Shishido Y, Hoshi H, Nakayama M, Totsune K, Satoh H, Sato H, Imai Y . Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant 2012; 27: 3218 –3223. E-Ib
Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J, Kanba S, Iwaki T, Kiyohara Y . Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension 2011; 58: 22 –28. E-Ib
Hozawa A, Okamura T, Murakami Y, Kadowaki T, Okuda N, Takashima N, Hayakawa T, Kita Y, Miura K, Nakamura Y, Okayama A, Ueshima H . NIPPON DATA80 Research Group. High blood pressure in middle age is associated with a future decline in activities of daily living. NIPPON DATA80. J Hum Hypertens 2009; 23: 546 –552. E-Ib
Murakami Y, Hozawa A, Okamura T, Ueshima H . Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN. Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension 2008; 51: 1483 –1491. E-Ia
Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K . What has made the population of Japan healthy?. Lancet 2011; 378: 1094 –1105. E-Ia
Turin TC, Murakami Y, Miura K, Rumana N, Kita Y, Hayakawa T, Okamura T, Okayama A, Ueshima H . NIPPON DATA80/90 Research Group. Hypertension and life expectancy among Japanese: NIPPON DATA80. Hypertens Res 2012; 35: 954 –958. E-Ib
Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayakawa T, Kita Y, Saitoh S, Okayama A, Ueshima H . NIPPON DATA 80 Research Group. Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980–1994. Circ J 2006; 70: 960 –964. E-Ib
Nakamura K, Nakagawa H, Sakurai M, Murakami Y, Irie F, Fujiyoshi A, Okamura T, Miura K, Ueshima H . EPOCH-JAPAN Research Group. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies. Cerebrovasc Dis 2012; 33: 480 –491. E-Ia
Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Furukawa Y, Kamide K, Kawanishi K, Okayama A, Yoshimasa Y . The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study. Hypertens Res 2010; 33: 1238 –1243. E-Ib
Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H . Japan Arteriosclerosis Longitudinal Study Group. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 2008; 118: 2694 –2701. E-Ia
Kokubo Y, Nakamura S, Okamura T, Yoshimasa Y, Makino H, Watanabe M, Higashiyama A, Kamide K, Kawanishi K, Okayama A, Kawano Y . Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke 2009; 40: 2674 –2679. E-Ib
Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T, Shimamoto K . Metabolic syn drome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men—the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203 –208. E-Ib
Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, Cui R, Tanigawa T, Shimamoto T . Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007; 38: 1744 –1751. E-Ib
Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y . Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 2007; 38: 2063 –2069. E-Ib
Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S . JPHC Study Group. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res 2009; 32: 289 –298. E-Ib
Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, Okayama A, Tomoike H . Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the Suita study. Hypertens Res 2008; 31: 2027 –2035. E-Ib
Chei CL, Yamagishi K, Tanigawa T, Kitamura A, Imano H, Kiyama M, Sato S, Iso H . Metabolic syndrome and the risk of ischemic heart disease and stroke among middle-aged Japanese. Hypertens Res 2008; 31: 1887 –1894. E-Ib
Irie F, Iso H, Noda H, Sairenchi T, Otaka E, Yamagishi K, Doi M, Izumi Y, Ota H . Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study. Circ J 2009; 73: 1635 –1642. E-Ib
Saito I, Konishi M, Watanabe K, Kondo H, Fujimoto K, Okada . The metabolic syndrome and risk of stroke in a rural community in Japan. Jpn J Publ Health 2007; 54: 677 –683. Japanese. E-Ib
Kadota A, Hozawa A, Okamura T, Kadowak T, Nakmaura K, Murakami Y, Hayakawa T, Kita Y, Okayama A, Nakamura Y, Kashiwagi A, Ueshima H . NIPPON DATA Research Group. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990–2000. Diabetes Care 2007; 30: 1533 –1538. E-Ib
Ohashi Y, Shimamoto K, Sato S, Iso H, Kita Y, Kitamura A, Saito I, Kiyohara Y, Kawano H, Nakagawa H, Toyoshima H, Ando T, Taguri M, Harada A, Ueshima H . Japan Arteriosclerosis Longitudinal Study Group. Association of obesity and other cardiovascular risk factors with stroke : The Japan Arteriosclerosis Longitudinal Study - Existing Cohorts Combined (JALS-ECC). Jpn J Publ Health 2011; 58: 1007 –1015. Japanese. E-Ia
Miura K, Nakagawa H, Ohashi Y, Harada A, Taguri M, Kushiro T, Takahashi A, Nishinaga M, Soejima H, Ueshima H . Japan Arteriosclerosis Longitudinal Study (JALS) Group. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies. Circulation 2009; 119: 1892 –1898. E-Ia
Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, Suh I, Rodgers A . Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension 2003; 42: 69 –75. E-Ia
Inoue R, Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hoshi H, Hashimoto J, Totsune K, Satoh H, Kondo Y, Imai Y . Predicting stroke using 4 ambulatory blood pressure monitoring-derived blood pressure indices: the Ohasama Study. Hypertension 2006; 48: 877 –882. E-Ib
Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y . Ohasama Study. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099 –1104. E-Ib
Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y . Prognosis of’masked’hypertension and’white-coat’hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508 –515. E-Ib
Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y . Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000; 18: 847 –854. E-Ib
Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y . Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45: 240 –245. E-Ib
Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319 –328. E-II
Stamler J, Elliott P, Chan Q . INTERMAP appendix tables. J Hum Hypertens 2003; 17: 665 –675. E-III
The Ministry of Health, Labour, and Welfare. The results of the 2011 National Health and Nutrition Survey in Japan. 2013, Japanese. E-III
Kojima S, et al. Environmental changes during the past 10 to 20 years and changes in cardiovascular disease. A. Dietary changes and cardiovascular disease in agricultural villages in Akita Prefecture, (1) State from 1950 until 1965. In Komachi Y, et al. (eds), Changes in Cardiovascular Disease/Association Between Nutrition and Environment in the Japanese (in Japanese). Hoken-Dojin-sha: Tokyo, 1987, pp 120 –138. E-III
The Ministry of Health Labour Welfare. Dietary Reference Intakes (2010) Report from the Review Board to Prepare the ‘Reference Dietary Intake for the Japanese’. The Ministry of Health, Labour, and Welfare 2009, Japanese. GL
Minister of Health, Labour and Welfare. Ministry of Health. Labour and Welfare Notification No. 430/Basic Strategies to Comprehensively Promote National Health. 2012. Japanese
WHO. Guideline: Sodium intake for adults and children. Geneva: World Health Organization (WHO); 2012. GL
Yoshiike N, Seino F, Tajima S, Arai Y, Kawano M, Furuhata T, Inoue S . Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976–1995. Obes Rev 2002; 3: 183 –190. E-II
OECD Health Data 2012. E-III
Rose G . The Strategy of Preventive Medicine Oxford University Press: New York, 1992.
Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas JM . National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288: 1882 –1888. GL
Special Committee for Establishing the Next-Phase National Health Exercise Plan, Regional Health/Health Promotion Nutritional Section, Health Science Council. Reference materials on the promotion of Health Japan 21 (II). The Ministry of Health, Labour, and Welfare, 2012. Japanese
National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med 1993; 153: 186–208
Committee on Strategies to Reduce Sodium Intake Food and Nutrition Board, Institute of Medicine. Strategies to reduce salt intake in the United States The National Academies Press: Washington, DC, 2010.
Health Service Bureau, Ministry of Health, Labour and Welfare. Standard Health Checkup/Health Guidance Program (revision). The Ministry of Health, Labour, and Welfare, 2013. Japanese
Fagard RH, Staessen JA, Thijs L . Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997; 29: 22 –29. IVb
Rights and permissions
About this article
Cite this article
Chapter 1. Epidemiology of hypertension. Hypertens Res 37, 260–265 (2014). https://doi.org/10.1038/hr.2014.4
Published:
Issue Date:
DOI: https://doi.org/10.1038/hr.2014.4